202 related articles for article (PubMed ID: 36399512)
21. Activities of transmitted/founder and chronic clade B HIV-1 Vpu and a C-terminal polymorphism specifically affecting virion release.
Jafari M; Guatelli J; Lewinski MK
J Virol; 2014 May; 88(9):5062-78. PubMed ID: 24574397
[TBL] [Abstract][Full Text] [Related]
22. Mechanism of Interferon-Stimulated Gene Induction in HIV-1-Infected Macrophages.
Nasr N; Alshehri AA; Wright TK; Shahid M; Heiner BM; Harman AN; Botting RA; Helbig KJ; Beard MR; Suzuki K; Kelleher AD; Hertzog P; Cunningham AL
J Virol; 2017 Oct; 91(20):. PubMed ID: 28768867
[TBL] [Abstract][Full Text] [Related]
23. Vpu-Mediated Counteraction of Tetherin Is a Major Determinant of HIV-1 Interferon Resistance.
Kmiec D; Iyer SS; Stürzel CM; Sauter D; Hahn BH; Kirchhoff F
mBio; 2016 Aug; 7(4):. PubMed ID: 27531907
[TBL] [Abstract][Full Text] [Related]
24. Resistance mutations outside the integrase coding region have an effect on human immunodeficiency virus replicative fitness but do not affect its susceptibility to integrase strand transfer inhibitors.
Weber J; Rose JD; Vazquez AC; Winner D; Margot N; McColl DJ; Miller MD; Quiñones-Mateu ME
PLoS One; 2013; 8(6):e65631. PubMed ID: 23776513
[TBL] [Abstract][Full Text] [Related]
25. HLA Class I Downregulation by HIV-1 Variants from Subtype C Transmission Pairs.
Ende Z; Deymier MJ; Claiborne DT; Prince JL; Mónaco DC; Kilembe W; Allen SA; Hunter E
J Virol; 2018 Apr; 92(7):. PubMed ID: 29321314
[TBL] [Abstract][Full Text] [Related]
26. Enhanced resistance to HIV-1 replication in U937 cells stably transfected with the human IFN-beta gene behind an MHC promoter fragment.
Mace K; Seif I; Anjard C; De Maeyer-Guignard J; Dodon MD; Gazzolo L; De Maeyer E
J Immunol; 1991 Nov; 147(10):3553-9. PubMed ID: 1940355
[TBL] [Abstract][Full Text] [Related]
27. HIV-1 Envelope Glycoprotein Amino Acids Signatures Associated with Clade B Transmitted/Founder and Recent Viruses.
Kafando A; Martineau C; El-Far M; Fournier E; Doualla-Bell F; Serhir B; Kazienga A; Sangaré MN; Sylla M; Chamberland A; Charest H; Tremblay CL
Viruses; 2019 Nov; 11(11):. PubMed ID: 31683782
[TBL] [Abstract][Full Text] [Related]
28. Altered viral fitness and drug susceptibility in HIV-1 carrying mutations that confer resistance to nonnucleoside reverse transcriptase and integrase strand transfer inhibitors.
Hu Z; Kuritzkes DR
J Virol; 2014 Aug; 88(16):9268-76. PubMed ID: 24899199
[TBL] [Abstract][Full Text] [Related]
29. Complex Interplay between HIV-1 Capsid and MX2-Independent Alpha Interferon-Induced Antiviral Factors.
Bulli L; Apolonia L; Kutzner J; Pollpeter D; Goujon C; Herold N; Schwarz SM; Giernat Y; Keppler OT; Malim MH; Schaller T
J Virol; 2016 Aug; 90(16):7469-7480. PubMed ID: 27279606
[TBL] [Abstract][Full Text] [Related]
30. Accumulated mutations by 6 months of infection collectively render transmitted/founder HIV-1 significantly less fit.
Wang C; Liu D; Zuo T; Hora B; Cai F; Ding H; Kappes J; Ochsenbauer C; Kong W; Yu X; Bhattacharya T; Perelson AS; Gao F
J Infect; 2020 Feb; 80(2):210-218. PubMed ID: 31812703
[TBL] [Abstract][Full Text] [Related]
31. Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1.
Klein K; Nankya I; Nickel G; Ratcliff AN; Meadows AAJ; Hathaway N; Bailey JA; Stieh DJ; Cheeseman HM; Carias AM; Lobritz MA; Mann JFS; Gao Y; Hope TJ; Shattock RJ; Arts EJ
J Virol; 2021 Jan; 95(3):. PubMed ID: 33177204
[TBL] [Abstract][Full Text] [Related]
32. Interferon Alpha Subtype-Specific Suppression of HIV-1 Infection In Vivo.
Lavender KJ; Gibbert K; Peterson KE; Van Dis E; Francois S; Woods T; Messer RJ; Gawanbacht A; Müller JA; Münch J; Phillips K; Race B; Harper MS; Guo K; Lee EJ; Trilling M; Hengel H; Piehler J; Verheyen J; Wilson CC; Santiago ML; Hasenkrug KJ; Dittmer U
J Virol; 2016 Jul; 90(13):6001-6013. PubMed ID: 27099312
[TBL] [Abstract][Full Text] [Related]
33. Interferon-Stimulated Gene (ISG)-Expression Screening Reveals the Specific Antibunyaviral Activity of ISG20.
Feng J; Wickenhagen A; Turnbull ML; Rezelj VV; Kreher F; Tilston-Lunel NL; Slack GS; Brennan B; Koudriakova E; Shaw AE; Rihn SJ; Rice CM; Bieniasz PD; Elliott RM; Shi X; Wilson SJ
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695422
[TBL] [Abstract][Full Text] [Related]
34. Differential expression of interferon-lambda receptor 1 splice variants determines the magnitude of the antiviral response induced by interferon-lambda 3 in human immune cells.
Santer DM; Minty GES; Golec DP; Lu J; May J; Namdar A; Shah J; Elahi S; Proud D; Joyce M; Tyrrell DL; Houghton M
PLoS Pathog; 2020 Apr; 16(4):e1008515. PubMed ID: 32353085
[TBL] [Abstract][Full Text] [Related]
35. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
36. Impact on replicative fitness of the G48E substitution in the protease of HIV-1: an in vitro and in silico evaluation.
Zimmer JM; Roman F; Lambert C; Jonckheer A; Vazquez A; Plesséria JM; Servais JY; Covens K; Weber J; Van Laethem K; Schmit JC; Vandamme AM; Quinones-Mateu ME; De Maeyer M
J Acquir Immune Defic Syndr; 2008 Jul; 48(3):255-62. PubMed ID: 18545158
[TBL] [Abstract][Full Text] [Related]
37. TRIM69 Inhibits Vesicular Stomatitis Indiana Virus.
Rihn SJ; Aziz MA; Stewart DG; Hughes J; Turnbull ML; Varela M; Sugrue E; Herd CS; Stanifer M; Sinkins SP; Palmarini M; Wilson SJ
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375575
[TBL] [Abstract][Full Text] [Related]
38. Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.
Nijhuis M; van Maarseveen NM; Boucher CA
Handb Exp Pharmacol; 2009; (189):299-320. PubMed ID: 19048205
[TBL] [Abstract][Full Text] [Related]
39. FEZ1 Plays Dual Roles in Early HIV-1 Infection by Independently Regulating Capsid Transport and Host Interferon-Stimulated Gene Expression.
Malikov V; Naghavi MH
J Virol; 2023 Jun; 97(6):e0049923. PubMed ID: 37219433
[TBL] [Abstract][Full Text] [Related]
40. Resistance of Transmitted Founder HIV-1 to IFITM-Mediated Restriction.
Foster TL; Wilson H; Iyer SS; Coss K; Doores K; Smith S; Kellam P; Finzi A; Borrow P; Hahn BH; Neil SJD
Cell Host Microbe; 2016 Oct; 20(4):429-442. PubMed ID: 27640936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
